Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PBM stock hub

Psyence Biomedical Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PBMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PBM

In the news

Latest news · PBM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-74.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-43.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PBM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001985062
Company name	Psyence Biomedical Ltd.
Country	Canada
Country code	US
Cusip	74449F407
Employees	12
Enterprise value	$5.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA74449F4078
Last refreshed	2026-05-10
Market cap	$12.8M
Market cap category	Nano-Cap
Price	$5.59
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	PBM
Website	https://www.psyencebiomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.75%
FCF yield	-33.16%
P/B ratio	0.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-3.9M
Net Income Growth Years	1%
Profit Per Employee	$-328,466
Profitable Years	1
ROA	-34.44
ROCE	-34.98
ROE	-74.29
ROIC	-43.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-79.1%
Cagr3y	-94.81%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$12.8M
Cash	$7.1M
Current Assets	$7.6M
Current Liabilities	$943,068
Equity	$11.9M
Interest Coverage	-388.6
Liabilities	$943,068
Long Term Assets	$5.2M
Long Term Liabilities	$0
Net Cash	$7.1M
Net Cash By Market Cap	$55.77
Net Cash Growth	1,032.45%
Net Debt Equity	$-0.6
Tangible Book Value	$11.9M
Tangible Book Value Per Share	$39.62
WACC	14.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.09
Net Working Capital	$-463,598
Quick ratio	7.77
Working Capital	$6.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-831.86%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-79.08%
200-day SMA	12.78
3Y total return	-99.99%
50-day SMA	4.12
50-day SMA vs 200-day SMA	50under200
All Time High	54,358
All Time High Change	-99.99%
All Time High Date	2023-11-22
All Time Low	1.92
All Time Low Change	191.15%
All Time Low Date	2026-02-23
ATR	1.32
Beta	1.79
Beta1y	10.63
Beta2y	4.93
Ch YTD	18.71
High	5.99
High52	74.94
High52 Date	2025-07-25
High52ch	-92.54%
Low	5.41
Low52	1.92
Low52 Date	2026-02-23
Low52ch	191.15%
Ma50ch	35.78%
Premarket Change Percent	-1.68
Premarket Price	$5.92
Premarket Volume	9,809
Price vs 200-day SMA	-56.27%
RSI	49.73
RSI Monthly	12.57
RSI Weekly	33.4
Sharpe ratio	0.17x
Sortino ratio	0.35
Total Return	-831.86%
Tr YTD	18.72
Tr1m	123.6%
Tr1w	-10.56%
Tr3m	78.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-4.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,240,227%
Float Percent	97.69%
Shares Insiders	2.29%
Shares Institutions	9.08%
Shares Out	2,293,307
Shares Qo Q	39.84%
Shares Yo Y	831.86%
Short Float	1.93%
Short Ratio	2.19
Short Shares	1.88

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-4.3M
Average Volume	7,283,290.3x
Bv Per Share	39.62
CAPEX	$-3,677
Ch1m	123.6
Ch1w	-10.56
Ch1y	-79.08
Ch3m	78.59
Ch3y	-99.99
Ch6m	-61.28
Change	-7.14%
Change From Open	-5.25
Close	6.02
Days Gap	-1.99
Depreciation Amortization	5,113
Dollar Volume	752,592.9
Earnings Date	2026-06-25
Earnings Time	bmo
EBIT	$-4.2M
EBITDA	$-4.1M
EPS	$-34.78
F Score	1
FCF	$-4.3M
FCF EV Yield	-74.98x
FCF Per Share	$-1.85
Financing CF	13,486,231
Fiscal Year End	March
Founded	1,994
Investing CF	-4,021,257
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-01-23
Last Report Date	2025-09-30
Last Split Date	2026-02-02
Last Split Type	Reverse
Last10k Filing Date	2025-06-25
Ma150	8.53
Ma150ch	-34.47%
Ma20	6.53
Ma20ch	-14.4%
Net CF	5,217,466
Next Earnings Date	2026-05-22
Open	5.9
Optionable	No
Position In Range	31.03
Post Close	5.59
Postmarket Change Percent	-3.22
Postmarket Price	$5.41
Ppne	8,690
Pre Close	6.02
Price Date	2026-05-08
Ptbv Ratio	1.08
Relative Volume	0.02x
Share Based Comp	26,329
Tr6m	-61.28%
Volume	134,632

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PBM pay a dividend?

Capital-return profile for this ticker.

Performance

PBM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PBM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.1%

Float: +97.7% of shares outstanding

Insider ownership

+2.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PBM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.7

Neutral momentum band

Price vs 200-day MA

-56.3%

50/200-day relationship not available

Beta (5Y)

1.79

More volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PBM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PBM stock rating?

Psyence Biomedical Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PBM analysis?

The full report lives at /stocks/PBM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PBM?

The latest report frames PBM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PBM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.